https://www.selleckchem.com/pr....oducts/selonsertib-g
sing on hemodynamics and biomarkers of organ damage during the initial 72 h. In addition, pro-inflammatory and anti-inflammatory cytokines will be measured to assess if cytokine patterns are modulated by IL-6 receptor blockage. ClinicalTrials.gov Identifier NCT03863015 ; submitted February 22, 2019, first posted March 5, 2019. EudraCT 2018-002686-19; date study was authorized to proceed November 7, 2018. ClinicalTrials.gov Identifier NCT03863015 ; submitted February 22, 2019, first posted March 5, 2019. EudraCT 2018-002686-1
Like
Comment
Share
